ArticlePloS one2026
Features of mobile apps for diabetic kidney disease self-management: A scoping review.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic kidney disease (DKD) is a chronic complication of diabetes mellitus (DM). DKD and chronic kidney disease (CKD) are both long-term conditions requiring ongoing patient care. Individuals living with DKD or CKD can benefit from mobile apps that support effective self-management. However, limited evidence is available about what mobile apps features are commonly included for DKD.
objectiveThis scoping review aimed to identify the features of mobile applications on self-management for individuals with DKD, DM or CKD.
methodsThe review followed the Joanna Briggs Institute (JBI) methodology for scoping reviews and adhered to PRISMA-ScR reporting guidelines. Five databases (PubMed, Scopus, SAGE Journals, ScienceDirect, and Web of Science) were searched from inception to February 26, 2025. Studies were included if they reported on mobile apps supporting self-management in adults with DKD, DM or CKD. DM and CKD apps were included due to similar self-management needs such as blood sugar or blood pressure tracking that are also relevant to people with DKD. Data were extracted on study characteristics, app features, use of technology, integration with care teams, and reported outcomes.
resultsOut of 3521 records identified, eleven studies met the inclusion criteria. Five studies focused on CKD, two on DKD, and four on diabetes. Across the eleven mobile apps reviewed, four core domains of self-management were identified: self-care monitoring (91%), educational components (64%), patient support and motivation (100%), and performance incentives (18%). Four apps employed wearable devices and incorporated supportive devices such as Bluetooth glucometers. However, only two apps included real-time communication features with providers integration with healthcare teams and gamification strategies.
conclusionsMobile apps targeting DKD frequently incorporate monitoring, education, and motivational features. However, consistent integration with healthcare providers and incentive-based engagement strategies remains limited. Future app development should emphasise personalised feedback, clinical integration, and sustained engagement mechanisms to enhance usability and impact.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.